Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: Effects of 'remote preconditioning'

Journal of the American College of Cardiology

Volumn 33, Issue 2, 1999, Pages 556-564

  Takaoka, Atsushi ^a   Nakae, Ichiro ^a   Mitsunami, Kenichi ^a   Yabe, Takahiro ^a   Morikawa, Shigehiro ^a   Inubushi, Toshiro ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; KIDNEY ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ENERGY METABOLISM; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; INTRACELLULAR FLUID; ISCHEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; KIDNEY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHOSPHOCREATINE; PILOT PROJECTS; RABBITS; RECEPTORS, PURINERGIC P1; THEOPHYLLINE;

EID: 0033081837     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00559-2     Document Type: Article

References (37)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Murry C.E., Richard V.J., Reimer K.A., Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:1990;913-931.
3. Zager R.A., Baltes L.A., Sharma H.M., Jurkowitz M.S. Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int. 26:1984;689-700.
4. Przyklenk K., Bauer B., Ovize M., Kloner R.A., Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 87:1993;893-899.
5. Gho B.C.G., Schoemaker R.G., Van den Doel M.A., Duncker D.J., Verdouw P.D. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 94:1996;2193-2200.
6. Flaherty J.T., Weisfeldt M.L., Bulkley B.H., Gardner T.J., Gott V.L., Jacobus W.E. Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation. 65:1982;561-571.
7. Wroblewski L.C., Aisen A.M., Swanson S.D., Buda A.J. Evaluation of myocardial viability following ischemic and reperfusion injury using phosphorus 31 nuclear magnetic resonance spectroscopy in vivo. Am Heart J. 120:1990;31-39.
8. Kida M., Fujiwara H., Ishida M., et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 84:1991;2495-2503.
9. Marcovitz P.M., Aisen A.M., Fencil L.E., Swanson S.D., Buda A.J. Metabolic effects of adenosine on regional myocardial ischemia by phosphorus 31 nuclear magnetic resonance spectroscopy. Am Heart J. 124:1992;1205-1212.
10. Miyamae M., Fujiwara H., Kida M., et al. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation. 88:1993;223-234.
11. Yokota R., Fujiwara H., Miyamae M., et al. Transient adenosine infusion before ischemia and reperfusion protects against metabolic damage in pig hearts. Am J Physiol. 268:1995;H1149-H1157.
12. Maxwell M.P., Hearse D.J., Yellon D.M. Species variation in the coronary collateral circulation during regional myocardial ischaemia a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 21:1987;737-746.
13. Miura T., Downey J.M., Ooiwa H., et al. Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J. 30:1989;695-708.
14. Liu G.S., Thornton J., Van Winkle D.M., Stanley A.W.H., Olsson R.A., Downey J.M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
15. Miura T., Ogawa T., Iwamoto T., Shimamoto K., Iimura O. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation. 86:1992;979-985.
16. Mosca S.M., Gelpi R.J., Cingolani H.E. Adenosine and dipyridamole mimic the effects of ischemic preconditioning. J Mol Cell Cardiol. 26:1994;1403-1409.
17. Toombs C.F., McGee D.S., Johnston W.E., Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation. 86:1992;986-994.
18. 31P-NMR. Biochim Biophys Acta. 1117:1992;251-257.
19. Vivaldi M.T., Kloner R.A., Schoen F.J. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol. 121:1985;522-530.
20. Connelly C., Vogel W.M., Hernandez Y.M., Apstein C.S. Movement of necrotic wavefront after coronary occlusion in rabbit. Am J Physiol. 243:1982;H682-H690.
21. de Albuquerque C.P., Gerstenblith G., Weiss R.G. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res. 74:1994;139-150.
22. Ichihara K., Abiko Y. Rebound recovery of myocardial creatine phosphate with reperfusion after ischemia. Am Heart J. 108:1984;1594-1597.
23. Li G.C., Vasquez J.A., Gallagher K.P., Lucchesi B.R. Myocardial protection with preconditioning. Circulation. 82:1990;609-619.
24. Bottomley P.A., Weiss R.G., Hardy C.J., Baumgartner W.A. Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. Radiology. 181:1991;67-75.
25. Hu K., Nattel S. Mechanisms of ischemic preconditioning in rat hearts. Involvement of α1B-adenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation. 92:1995;2259-2265.
26. Steenbergen C., Perlman M.E., London R.E., Murphy E. Mechanism of preconditioning. Ionic alterations. Circ Res. 72:1993;112-125.
27. Auchampach J.A., Gross G.J. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol. 264:1993;H1327-H1336.
28. Thornton J.D., Liu G.S., Downey J.M. Pretreatment with pertussis toxin blocks the protective effects of preconditioning evidence for a G-protein mechanism. J Mol Cell Cardiol. 25:1993;311-320.
29. Li Y., Kloner R.A. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation. 87:1993;1642-1648.
30. Grover G.J., Dzwonczyk S., Sleph P.G., Sargent C.A. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther. 265:1993;559-564.
31. Hata K., Kloner R.A., Przyklenk K. Brief myocardial ischemia attenuates platelet aggregation in remote, damaged and stenotic rabbit carotid arteries. [abstract] J Am Coll Cardiol. 31:1998;168A.
32. Cope D.K., Impastato W.K., Cohen M.V., Downey J.M. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology. 86:1997;699-709.
33. Kersten J.R., Schmeling T.J., Pagel P.S., Gross G.J., Warltier D.C. Isoflurane mimics ischemic preconditioning via activation of KATP channels. Anesthesiology. 87:1997;361-370.
34. Thornton J.D., Thornton C.S., Sterling D.L., Downey J.M. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res. 72:1993;44-49.
35. Tooms C.F., Moore T.L., Shebuski R.J. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res. 27:1993;617-622.
36. + exchange inhibitor, Hoe 642 difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol. 29:1997;693-701.
37. Capecchi P.L., Laghi Pasini F., Cati G., et al. Experimental model of short-time exercise-induced preconditioning in POAD patients. Angiology. 48:1997;469-480.